GO:0003921 GMP synthase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003921 (GMP synthase activity) catalyzes the ATP-dependent conversion of XMP and ammonium to GMP, AMP, diphosphate, and two protons.
• The enzyme is a glutamine amidotransferase that uses a catalytic cysteine to generate ammonia from glutamine, which then attacks XMP.
• GMP synthase (GMPS) is allosterically regulated and is essential for GTP biosynthesis, influencing cell proliferation and virulence.
• In Cryptococcus neoformans, GMP synthase is required for virulence factor production and infection.
• In lung adenocarcinoma, circulating metabolomics identified GMPS as a novel therapeutic target.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise dissection of GMP synthase function in health and disease.
Description
GMP synthase activity (GO:0003921) is a molecular function that catalyzes the final step of guanine nucleotide biosynthesis: the conversion of xanthosine monophosphate (XMP) to guanosine monophosphate (GMP) using ATP and ammonium. This reaction is essential for maintaining cellular GTP pools, which are required for DNA and RNA synthesis, protein translation, and signal transduction. Because GMP synthase (GMPS) sits at the crossroads of purine metabolism, its dysregulation has been linked to cancer, microbial virulence, and developmental disorders. Understanding the mechanistic details of GMP synthase activity is therefore critical for both basic biology and therapeutic development. Researchers study this enzyme using structural biology, enzymology, and CRISPR-based genetic models to uncover how its activity is controlled and how it can be targeted in disease.
GMP synthase activity At A Glance
| GO ID | GO:0003921 |
|---|---|
| GO term | GMP synthase activity |
| Ontology | molecular_function |
| Synonym | None |
| Definition | Catalysis of the reaction: ATP + XMP + NH4+ = AMP + diphosphate + GMP + 2H+. |
| Major function | Final step of guanine nucleotide biosynthesis; converts XMP to GMP. |
| EC number | 6.3.5.2 (GMP synthase (glutamine-hydrolyzing)). |
| Cofactors | ATP, Mg2+ (implied by ATP-dependent reaction). |
| Subcellular location | Cytoplasm (typical for purine biosynthesis). |
What Is GO:0003921?
GMP synthase activity (GO:0003921) is defined by the Gene Ontology as the catalysis of the reaction: ATP + XMP + NH4+ = AMP + diphosphate + GMP + 2H+. In other words, it is the enzyme activity that attaches ammonia to XMP, forming GMP, while consuming ATP and releasing AMP and pyrophosphate. This activity is typically associated with a glutamine amidotransferase domain that hydrolyzes glutamine to supply ammonia for the reaction.
Why Is GMP synthase activity Important in Cell Biology?
GMP synthase activity is essential for the de novo synthesis of guanine nucleotides, which are required for RNA, DNA, and GTP-dependent processes such as signal transduction and protein synthesis. Because rapidly dividing cells have a high demand for guanine nucleotides, GMP synthase is a potential target in cancer and infectious diseases. Moreover, mutations or dysregulation of GMPS can disrupt cellular homeostasis and contribute to disease pathogenesis.
• Provides the final step in guanine nucleotide biosynthesis, feeding into GTP pools.
• Essential for cell proliferation due to high demand for guanine nucleotides.
• Required for virulence factor production in Cryptococcus neoformans.
• Identified as a therapeutic target in lung adenocarcinoma via metabolomics.
• Allosteric regulation allows fine-tuning of GTP biosynthesis.
• Glutamine amidotransferase mechanism links nitrogen metabolism to nucleotide synthesis.
• Potential target for antimicrobial and anticancer drug development.
• Involved in cellular responses to oxidative stress through GTP-dependent pathways.
What Happens During GMP synthase activity?
Substrate Binding and Activation
In simple terms: The enzyme grabs XMP and ATP to start the reaction.
GMP synthase binds XMP and ATP in its active site, positioning them for catalysis. ATP is used to activate XMP by adenylylation, forming an intermediate that facilitates ammonia attack.
Ammonia Generation from Glutamine
In simple terms: The enzyme extracts ammonia from glutamine to use as a building block.
The glutamine amidotransferase domain hydrolyzes glutamine to glutamate and ammonia, which is channeled to the active site. This mechanism ensures that ammonia is delivered directly to the XMP intermediate, preventing wasteful release.
Formation of GMP and Release of Byproducts
In simple terms: The ammonia attacks XMP, making GMP, and the leftover AMP and pyrophosphate are released.
The ammonia attacks the activated XMP, displacing AMP and forming GMP. The reaction releases AMP, diphosphate, and two protons, completing the catalytic cycle.
Allosteric Regulation and Conformational Changes
In simple terms: The enzyme changes shape to control its activity.
GMP synthase undergoes allosteric regulation by nucleotides such as GMP and AMP, which modulate its activity. Structural studies reveal that binding of substrates induces conformational changes that coordinate the two active sites.
Key Genes Involved in GO:0003921 GMP synthase activity
The following genes and proteins are directly involved in GMP synthase activity or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GMPS | Encodes GMP synthase, catalyzing XMP to GMP conversion | Target in cancer and infectious diseases |
| GAT | Glutamine amidotransferase domain of GMPS | Mechanistic studies of ammonia transfer |
| ATP | Substrate for adenylylation of XMP | Cofactor in enzymatic assays |
| XMP | Substrate converted to GMP | Metabolite in purine biosynthesis |
| GMP | Product of the reaction | Feedback regulator of GTP biosynthesis |
| AMP | Byproduct of the reaction | Allosteric regulator |
| GTP | Downstream product of GMP | Essential for signal transduction and translation |
| IMPDH | Converts IMP to XMP, upstream of GMPS | Target in immunosuppression and cancer |
| PRPP | Phosphoribosyl pyrophosphate, precursor in purine synthesis | Metabolic flux studies |
| Glutamine | Nitrogen donor for ammonia | Metabolic labeling experiments |
| STING | Cyclic dinucleotide binding protein, linked to GTP metabolism | Innate immunity studies |
| BcsA | Cellulose synthase, part of c-di-GMP signaling | Biofilm research |
| c-di-GMP | Second messenger in bacteria, related to GMP metabolism | Optogenetic control of biofilm |
| mTOR | Regulates nucleotide synthesis, including GTP | Cancer metabolism |
| MYC | Oncogene driving purine biosynthesis | Lung adenocarcinoma models |
| p53 | Tumor suppressor, linked to nucleotide metabolism | Stress response studies |
| NF-κB | Transcription factor influenced by GTP levels | Inflammation research |
How Is GMP synthase activity Regulated?
GMP synthase activity is regulated at multiple levels. Allosteric regulation by purine nucleotides such as GMP and AMP modulates enzyme activity. Additionally, GTP biosynthesis is controlled by feedback inhibition of upstream enzymes like IMPDH. In cancer, oncogenic signaling pathways such as mTOR and MYC can upregulate purine biosynthesis to support proliferation. In Cryptococcus neoformans, GMP synthase expression is required for virulence factor production, indicating transcriptional regulation during infection.
GMP synthase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GMPS | Lung adenocarcinoma | CRISPR knockout in A549 cells |
| GMPS | Cryptococcosis | Gene deletion in Cryptococcus neoformans |
| STING | Autoinflammatory diseases | Knock-in of STING mutations |
| IMPDH | Cancer, immunosuppression | Point mutation of catalytic residues |
| MYC | Lung adenocarcinoma | Overexpression in cell lines |
Cancer
GMP synthase (GMPS) is overexpressed in lung adenocarcinoma and correlates with poor prognosis. Circulating metabolomics identified GMPS as a novel therapeutic target, and its inhibition reduces tumor growth. The enzyme supports the high demand for guanine nucleotides in rapidly dividing cancer cells.
Infectious Diseases
In Cryptococcus neoformans, GMP synthase is essential for virulence factor production and infection. Deletion of the gene attenuates virulence in animal models, suggesting it as an antifungal target.
Innate Immunity and Inflammation
GTP metabolism intersects with innate immune signaling. STING, a key adaptor in cytosolic DNA sensing, binds cyclic dinucleotides and is influenced by GTP availability. Mitochondrial DNA release and oxidants can trigger inflammatory responses linked to nucleotide metabolism.
From GMP synthase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GMPS loss affect proliferation? | CRISPR knockout in cancer cell lines |
| How does allosteric regulation work? | Point mutations in allosteric sites |
| Can GMPS be targeted for antifungal therapy? | Knockout in Cryptococcus neoformans |
| What is the role of GMPS in GTP signaling? | Knock-in of tagged GMPS for imaging |
| Does GMPS overexpression drive tumorigenesis? | Overexpression in lung epithelial cells |
| How does GMPS interact with STING? | Co-immunoprecipitation in knockout backgrounds |
How to Study the GMP synthase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay | GMP synthase catalytic activity | Kinetic studies |
| X-ray crystallography | Three-dimensional structure | Inhibitor design |
| Metabolomics | Guanine nucleotide levels | Cancer biomarker discovery |
| CRISPR knockout | Gene function loss | Proliferation assays |
| RNA-seq | Transcriptional changes | Pathway analysis |
| Proteomics | Protein interactions | Complex identification |
| Imaging | Subcellular localization | Live-cell tracking |
Enzymatic Assays
GMP synthase activity can be measured spectrophotometrically by monitoring the conversion of XMP to GMP at 290 nm or by coupling to downstream enzymes. Radioactive assays using 14C-glutamine track ammonia transfer.
Structural Biology
X-ray crystallography and cryo-EM have revealed the architecture of GMP synthase, including the glutamine amidotransferase domain and allosteric sites. These studies guide inhibitor design.
Metabolomics
LC-MS-based metabolomics quantifies guanine nucleotides and intermediates, revealing flux through GMP synthase. Circulating metabolomics identified GMPS as a biomarker in lung cancer.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to GMP synthase inhibitors. Pooled screens with sgRNA libraries enable unbiased discovery of synthetic lethal interactions.
How CRISPR Can Be Used to Study GO:0003921 GMP synthase activity
Knockout
CRISPR knockout of GMPS in cancer cell lines reduces GTP levels and inhibits proliferation, validating it as a therapeutic target. In Cryptococcus neoformans, GMPS knockout attenuates virulence.
Point Mutation
Point mutations in the catalytic cysteine of the glutamine amidotransferase domain abolish ammonia transfer, allowing dissection of the two half-reactions. Allosteric site mutations reveal regulatory mechanisms.
Knock-in
Knock-in of epitope-tagged GMPS enables localization and interaction studies without altering endogenous regulation. Fluorescent tags allow live-cell imaging of enzyme dynamics.
Overexpression
Overexpression of GMPS in lung epithelial cells increases GTP pools and promotes proliferation, supporting its oncogenic role. Overexpression models help test drug resistance.
How EDITGENE Supports GMP synthase activity Research
Researchers studying GMP synthase activity-related genes often need to determine whether a candidate gene is causally involved in disease or metabolism. EDITGENE provides custom CRISPR cell models to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for GMP synthase activity research.
Frequently Asked Questions About GMP synthase activity
What is GMP synthase activity?
GMP synthase activity (GO:0003921) is the enzyme activity that converts XMP and ammonium to GMP, consuming ATP and releasing AMP and diphosphate.
What genes are involved in GMP synthase activity?
The primary gene is GMPS, which encodes the enzyme. Other genes include IMPDH, which produces XMP, and GTP-consuming pathways.
What is the reaction catalyzed by GMP synthase?
ATP + XMP + NH4+ = AMP + diphosphate + GMP + 2H+.
How is GMP synthase regulated?
It is allosterically regulated by purine nucleotides such as GMP and AMP, and its expression is controlled by oncogenic pathways like mTOR and MYC.
What diseases are associated with GMP synthase?
Lung adenocarcinoma and cryptococcosis are linked to GMPS dysregulation.
Can GMP synthase be targeted for cancer therapy?
Yes, GMPS is a potential therapeutic target in lung adenocarcinoma, and inhibitors are being explored.
What model systems are used to study GMP synthase?
CRISPR knockout, point mutation, knock-in, and overexpression cell models, as well as animal models of infection.
What is the role of GMP synthase in virulence?
In Cryptococcus neoformans, GMP synthase is required for virulence factor production and infection.
How is GMP synthase activity measured?
Enzymatic assays monitoring XMP to GMP conversion, often coupled with NADH oxidation, are standard.
What are the research methods for GMP synthase?
Enzymology, structural biology, metabolomics, CRISPR screening, and transcriptomics are commonly used.
Conclusion
GMP synthase activity (GO:0003921) is a critical enzymatic function in guanine nucleotide biosynthesis, with far-reaching implications for cancer, infectious diseases, and immune regulation. Understanding its mechanism, regulation, and role in disease provides a foundation for therapeutic development. CRISPR-based models offer powerful tools to dissect these functions in physiologically relevant contexts.
References
- 1. Hong Z et al.. 2021. STING inhibitors target the cyclic dinucleotide binding pocket.. Proc Natl Acad Sci U S A 118(24) PMID: 34099558
- 2. Teng A et al.. 2026. Engineering a High-Activity Photosensitive Synthase for Optogenetic Control of c-di-GMP and Biofilm Dynamics.. ACS Synth Biol 15(3):1090-1103 PMID: 41678751
- 3. Anso I et al.. 2024. Structural basis for synthase activation and cellulose modification in the E. coli Type II Bcs secretion system.. Nat Commun 15(1):8799 PMID: 39394223
- 4. Ballut L et al.. 2023. GMP Synthetase: Allostery, Structure, and Function.. Biomolecules 13(9) PMID: 37759779
- 5. Piantadosi CA. 2020. Mitochondrial DNA, oxidants, and innate immunity.. Free Radic Biol Med 152:455-461 PMID: 31958498
- 6. Chitty JL et al.. 2017. GMP Synthase Is Required for Virulence Factor Production and Infection by Cryptococcus neoformans.. J Biol Chem 292(7):3049-3059 PMID: 28062578
- 7. Weber G et al.. 1992. Regulation of GTP biosynthesis.. Adv Enzyme Regul 32:57-69 PMID: 1353938
- 8. Yu M et al.. 2025. Circulating metabolomics reveals guanosine monophosphate synthetase (GMPS) as a novel therapeutic target in lung adenocarcinoma.. J Pathol 266(4-5):465-480 PMID: 40539844
